Advanced Cardiovascular Life Support (ACLS) Practice Exam

Epinephrine is considered the first-line medication during cardiac arrest in Advanced Cardiovascular Life Support (ACLS) protocols primarily due to its potent vasoconstrictive properties. During cardiac arrest, particularly in cases of pulseless electrical activity (PEA) or ventricular fibrillation (VF), the administration of epinephrine helps to increase coronary perfusion pressure. This enhances the likelihood of achieving a successful return of spontaneous circulation (ROSC). Epinephrine works by stimulating alpha-adrenergic receptors, leading to vasoconstriction, which improves blood flow to the heart and brain during cardiopulmonary resuscitation (CPR).

In addition, the timing of epinephrine's administration is critical; it is recommended to be given every 3-5 minutes during ongoing resuscitation efforts. This consistent administration helps to maintain its beneficial effects throughout the resuscitation attempt.

The other options, such as amiodarone, lidocaine, and adenosine, have specific roles in the management of certain arrhythmias or conditions but are not the first-line treatments for cardiac arrest. Amiodarone might be used after defibrillation attempts in shock-refractory VF or pulseless VT, while lidocaine is primarily